BackInitiator Pharma A/S Overview

Initiator Pharma A/S Long Term Debt

Initiator Pharma A/S's long-term debt is $9.7M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$9.69M
↑ 342.55% YoYΔ $7.50M vs prior year quarter

Peer trimmed avg / median

Loading

Initiator Pharma A/S Long Term Debt History

Loading

Initiator Pharma A/S vs. peers: Long Term Debt Comparison

Loading

Initiator Pharma A/S Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Initiator Pharma A/S (INIT.ST) FAQ

The latest long-term debt for INIT.ST is $9.7M as of June 2026. That compares with $2.2M in the prior-year period — up 342.6% year over year. Investors often review this figure alongside Initiator Pharma A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, INIT.ST's long-term debt moved from $2.2M to $9.7M — a 342.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Initiator Pharma A/S's operating scale or balance-sheet position.

A long-term debt figure of $9.7M for INIT.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INIT.ST's long-term debt ($9.7M), review year-over-year change from $2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Initiator Pharma A/S's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.